Dan Blazer III, M.D.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (NCT03663712) | Dan Blazer III, M.D. | 2019-05-23 |
Track Dan Blazer III, M.D. automatically
Every clearance here is in the API, with alerts when new ones post.